Ask Anything
LIVEESC Congress 2026Munich · Aug 28-31 · Hot Line trials and the live discussion from MunichOpen the hub→Hot Research Today
Papers from every journal, all in one place. Create custom feeds.
ESC 2026 Hot LineRCT · n=5589 mentionsACC Journal Scan (X) Highlight
AUG 31KroupaNew England Journal of Medicine
Catheter-directed thrombolysis reduces mortality, PE recurrence, or decompensation ~90% vs standard anticoagulation.
Supports catheter-directed thrombolysis in intermediate-high-risk PE; confirms early-event reduction versus anticoagulation alone in this RCT.
VKViktor Kočka
In contrast to interventions for myocardial infarction or stroke, there have been very few advances in the treatment of [PE] over the last 20 years. This has led to a considerable unmet clinical need that we can't ignore.
RCT · n=12,2578 mentionsTrending on XCirculation Highlight
AUG 31GiuglianoCirculation
Evolocumab reduces all-cause mortality ~20% vs placebo in high-risk patients without prior MI or stroke.
Reduces all-cause mortality in high-risk patients without prior MI or stroke; extends VESALIUS-CV event reduction to survival benefit.
JBDr. Jay Bradner
Executive Vice President, Research and Development, Artificial Intelligence and Data, Amgen
For people at high risk of a heart attack or stroke, lowering LDL-C or 'bad' cholesterol with Repatha may do more than help prevent these events; it may also reduce the risk of dying from heart disease and its serious consequences. This is especially significant given cardiovascular disease remains the leading cause of death worldwide. The totality of these data is practice-changing and reinforces the importance of identifying high-risk patients early and lowering LDL-C aggressively and consistently with Repatha.
GuidelineTrending on X
SEP 1YehyaJACC Heart Failure
Defining Clinically Meaningful Within-Patient Changes in Heart Failure
Standardized HF health status thresholds aid trial interpretation; leaves open prospective validation before guiding endpoints or practice.
cohort · n=1,1256 mentions
SEP 2ManzanaresJACC Advances
Elevated HFpEF-ABA scores linked to ~141% higher risk of death or HF hospitalization.
The HFpEF-ABA score provides moderate diagnostic discrimination for HFpEF and identifies outpatients with type 2 diabetes at high risk for adverse clinical outcomes.
VSDr. Varun Sundaram
Heart Failure Cardiologist, University Hospitals Harrington Heart & Vascular Institute
With the new, simple scoring system, 'We are able to screen and effectively identify patients with a high probability of HFpEF at the population level.' We're tapping into an opportunity to elevate the standard of care, and it will change the paradigm for diagnosis for better identification of HFpEF at the community level.
cohort2 mentionsTrending on X
SEP 1BalNature Cardiovascular Research
Highest multiancestry PRS quintile linked to ~111% greater HCM risk.
Highest PRS quintile associated with elevated HCM risk in variant carriers; leaves open whether multiancestry PRS improves clinical stratification.
RCT · n=3202 mentionsTrending on X
SEP 1凌天佑EP Europace
First-line cryoballoon ablation cuts atrial tachyarrhythmia recurrence ~58% versus antiarrhythmic drugs.
Supports first-line cryoballoon ablation in treatment-naive persistent AF; extends randomized evidence from paroxysmal populations.
PHDr. Peter Steen Hansen
Cardiologist and Electrophysiologist, Rytmedoktor
For years, we have known that ablation is a safe and effective treatment for paroxysmal atrial fibrillation – episodes that come and go. However, there has been more skepticism regarding persistent atrial fibrillation, which does not resolve spontaneously. Several studies have shown that outcomes are generally less favorable in this group.
cohort · n=1,274,8631 mentionsTrending on X
SEP 2VermaCirculation Heart Failure
Hospital GWTG-HF participation is linked to ~0.15-point higher 90-day post-discharge GDMT scores versus non-participating hospitals.
GWTG-HF participation was associated with higher post-discharge GDMT scores; leaves open whether quality programs improve outcomes in HFrEF.
cohort · n=1551 mentions
SEP 1LiJournal of Cardiovascular Development and Disease
CT-derived EAT volume fails to improve CAD discrimination beyond conventional risk factors in adults ≥80 years.
EAT volume adds no CAD discrimination value in patients ≥80 years; leaves open its utility in younger cohorts or for other endpoints.
cohort · n=2,7031 mentionsTrending on X
SEP 1KatoCirculation Journal
A ≥25% increase in NT-proBNP over 5 years is linked to ~73% higher all-cause mortality.
May aid risk stratification via serial NT-proBNP in Asian adults; extends trajectory data but remains hypothesis-generating.
RCT2 mentions
SEP 2WadhwaEuropean Spine Journal
ACDF reoperation and pseudoarthrosis rates are elevated in CDA trials compared to observational studies: systematic review and meta-analysis
Systematic review and meta-analysis reveals higher ACDF reoperation and pseudoarthrosis rates in CDA trials versus observational cohorts, suggesting study design impacts reported fusion outcomes.